Sun Yat-sen University: Adenocarcinoma trials

The registry lists 11 Adenocarcinoma studies with Sun Yat-sen University as lead sponsor. 6 are open to participants now and 0 have results posted.

Phase 2 8Phase 3 2No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal CancerNot yet recruitingNCT06919510Phase 2
• PD-1 Antibody and Sapropterin Dihydrochloride in Patients With PDACRecruitingNCT06396637Phase 2
• Neoadjuvant Toripalimab for dMMR/MSI-H Gastric CancerRecruitingNCT05994456Phase 2
• Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction AdenocarcinomaRecruitingNCT05918094Phase 3
• A Phase II Clinical Study of Surufatinib Combined With Sintilimab in the Treatment of Advanced Gastric CancerRecruitingNCT05235906Phase 2
• Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction AdenocarcinomaRecruitingNCT05170503Phase 2
• Nab-Paclitaxel and Gemcitabine Plus Camrelizumab and Radiotherapy for Locally Advanced Pancreatic AdenocarcinomaStatus unknownNCT04365049
• Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver GeneStatus unknownNCT03905317Phase 2
• Bevacizumab After Chemoradiotherapy For Locally Advanced Lung AdenocarcinomaCompletedNCT03904563Phase 2
• S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma PatientsCompletedNCT01824459Phase 3
• A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of LungCompletedNCT00816868Phase 2